Reviva pharmaceuticals holdings inc RVPH.US Value Analysis
US StockHealth Care
(No presentation for RVPH)
RVPH Value Score
3
24
15
Poor Growth
- AI analysis rates RVPH with the lowest value score of 1.
- It is mainly due to unstable operating cash flow, along with potential higher debt.
- Over the past 3 months, RVPH has maintained a consecutive value rating of 1.0, matching its rating over the past 3 years, indicating continued decline in enterprise value.
- Compared to all stocks in the Health Care sector, RVPH has a lower value rating.
RVPH Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
No related data records
RVPH Financial Forecast
Unit : USD
Update to 2025/5/9 (Quarterly Update)
RVPH Earnings Table
No related data records
RVPH Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
RVPH Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of RVPH from 2019/05 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from May, 2019 to May, 2025. (Total Trades: 0)
| RVPH | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 45% | 54% |
| Avg Return | - | 62.9% | 72.8% |
| Avg Profit | - | 197.1% | 165.9% |
| Avg Loss | - | -45.1% | -34.6% |
| Avg Risk-Reward Ratio | - | 437% | 479.2% |
Update to 2025/5/10 (Daily Update)